Anebulo Pharmaceuticals Files 8-K
Ticker: ANEB · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1815974
| Field | Detail |
|---|---|
| Company | Anebulo Pharmaceuticals, Inc. (ANEB) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: ANBU
TL;DR
ANBU filed an 8-K on 4/15 for an event on 4/11, details pending.
AI Summary
Anebulo Pharmaceuticals, Inc. filed an 8-K on April 15, 2025, reporting an event that occurred on April 11, 2025. The filing is categorized under 'Other Events' and does not specify any significant financial transactions or corporate changes in the provided text.
Why It Matters
This filing indicates a corporate event has been reported by Anebulo Pharmaceuticals, Inc. to the SEC, requiring further review to understand its implications.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not contain information suggesting immediate financial risk or significant operational changes.
Key Players & Entities
- Anebulo Pharmaceuticals, Inc. (company) — Registrant
- April 11, 2025 (date) — Date of earliest event reported
- April 15, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 78734 (zip_code) — Principal Executive Offices Zip Code
FAQ
What specific event is reported under 'Other Events' in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' reported; it only indicates that such an event occurred on April 11, 2025.
When was this 8-K report filed with the SEC?
The 8-K report was filed as of April 15, 2025.
What is the principal executive office address for Anebulo Pharmaceuticals, Inc.?
The principal executive offices are located at 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734.
What is the Commission File Number for Anebulo Pharmaceuticals, Inc.?
The Commission File Number for Anebulo Pharmaceuticals, Inc. is 001-40388.
What is the fiscal year end for Anebulo Pharmaceuticals, Inc.?
The fiscal year end for Anebulo Pharmaceuticals, Inc. is June 30.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Anebulo Pharmaceuticals, Inc. (ANEB).